The Aspiration & Biopsy Needles Market Size is valued at USD 990.65 Mn in 2023 and is predicted to reach USD 1775.98 Mn by the year 2031 at a 7.62% CAGR during the forecast period for 2024-2031.
The market is being driven by factors such as the rising incidence of cancer, increased knowledge of the condition and available treatments, patient preference for minimally invasive surgeries, rising healthcare costs, and technological developments in image-guided biopsy systems.
According to Globocan 2020, there will be 2,261,419 new patients of breast cancer in 2020, & there will be 684,996 deaths worldwide as a result of breast cancer. Also, the same source shows that breast cancer is the most prevalent cancer among all cancers. The increased use of needle-based biopsy instruments for breast cancer testing is a result of the rising incidence and mortality of malignancies like breast cancer, showing the rapid expansion of this industry.
Additionally, governments worldwide are launching campaigns to increase cancer awareness and its diagnosis to enable early cancer detection. For instance, the health minister of Tamil Nadu, an Indian state, claimed in February 2022 that the government of Tamil Nadu is formulating a policy to identify 66% of cancer patients in the first and second stages by 2030, allowing for the provision of appropriate treatment. Therefore, it is anticipated that these policies will fuel market expansion.
In addition, throughout the anticipated period, the market is expected to be propelled by technical advances, product launches, and merger and acquisition activity by significant market participants. For example, in January 2021, Incorporating Somatex Medical Technologies with Hologic Inc. Hologic's strategy aims to offer an extensive array of cutting-edge solutions for every stage of breast health care.
The Aspiration & Biopsy Needles market is segmented based on product, application, procedure, and end-user. The market is segmented as biopsy needles and aspiration needles based on product. The application segment includes tumour/cancer application, breast cancer, lung cancer, colorectal cancer, prostate cancer, kidney cancer, bone & bone marrow cancer, other cancers, wound applications, and other applications.
The procedure segment includes Image-guided, and Non-image guided. Based on End-User, the segmentation is hospital & surgical centres, diagnostic clinics & pathology laboratories, ambulatory care centres, and research & academic institutes.
Globally, the incidence of breast cancer has dramatically increased in recent years, increasing the desire for more effective and precise treatment methods and, consequently, the market's expansion. According to the World Health Organization's March 2021 report, 685,000 women died from breast cancer in 2020, with an estimated 2.3 mn new cases. Breast cancer is among the ordinary types of cancer, with 7.8 million women alive today having received a diagnosis in the previous five years. Owing to the rising spread of breast cancer, there will be a greater need for breast biopsies, which will raise demand for biopsy and aspiration needles and spur sector expansion.
Throughout the projection period, the image-guided category is anticipated to experience stable revenue growth. The increased demand for image-guided needle biopsy treatments is primarily due to the ease of discovery because it allows the clinician to examine problematic spots that are either easily visible or cannot be felt through the skin. The growing popularity of minimally invasive biopsy is a key driver promoting the expansion of this market.
Due to the rising cancer prevalence, increased awareness of early cancer diagnosis, high healthcare spending, and the rising number of approved devices, Asia Pacific dominates the global market. It is predicted that a rise in cancer prevalence will raise the need for aspiration and biopsy needles for early diagnosis, ultimately fueling the market expansion in the area.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 990.65 Mn |
|
Revenue Forecast In 2031 |
USD 1774.98 Mn |
|
Growth Rate CAGR |
CAGR of 7.5% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million, volume (number of units) and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Application, Procedure, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
CONMED Corporation (US), Medtronic Plc (Ireland), Olympus Corporation (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), Rantac Corporation (US), HAKKO CO., LTD (Japan), and Merit Medical Systems (US) |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Aspiration & Biopsy Needles Market Snapshot
Chapter 4. Global Aspiration & Biopsy Needles Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2023-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:
5.2.1. Biopsy Needles
5.2.1.1. CNB Needles
5.2.1.2. VAB Needles
5.2.2. Aspiration Needles
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Product & Market Share, 2023-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
6.2.1. Tumor/ Cancer Applications
6.2.1.1. Breast Cancer
6.2.1.2. Lung Cancer
6.2.1.3. Colorectal Cancer
6.2.1.4. Prostate Cancer
6.2.1.5. Kidney Cancer
6.2.1.6. Bone & Bone Marrow Cancer
6.2.1.7. Other Cancers
6.2.2. Wound Applications
6.2.3. Other Applications
Chapter 7. Market Segmentation 3: By Procedure Estimates & Trend Analysis
7.1. By Product & Market Share, 2023-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Procedure:
7.2.1. Image-guided Procedures
7.2.1.1. Ultrasound-guided Procedures
7.2.1.2. Stereotactic Procedures
7.2.1.3. CT-guided Procedures
7.2.1.4. MRI-guided Procedures
7.2.1.5. Other Image-guided Procedures
7.2.2. Nonimage-guided Procedures
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By Product & Market Share, 2023-2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
8.2.1. Hospitals & surgical centers
8.2.2. Diagnostic Clinics & pathology laboratories
8.2.3. Ambulatory care centers
8.2.4. Research & Academic Institutes
Chapter 9. Aspiration & Biopsy Needles Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Product, 2019-2031
9.1.2. North America Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
9.1.3. North America Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Procedure, 2019-2031
9.1.4. North America Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By, End User 2019-2031
9.1.5. North America Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By country, 2019-2031
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Aspiration & Biopsy Needles Market revenue (US$ Million) By Product, 2019-2031
9.2.2. Europe Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
9.2.3. Europe Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Procedure, 2019-2031
9.2.4. Europe Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By End User ,2019-2031
9.2.5. Europe Aspiration & Biopsy Needles Market revenue (US$ Million) By country, 2019-2031
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Aspiration & Biopsy Needles Market revenue (US$ Million) By Product, 2019-2031
9.3.2. Asia Pacific Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
9.3.3. Asia Pacific Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Procedure, 2019-2031
9.3.4. Asia Pacific Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
9.3.5. Asia Pacific Aspiration & Biopsy Needles Market revenue (US$ Million) By country, 2019-2031
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Aspiration & Biopsy Needles Market revenue (US$ Million) By Product, 2019-2031
9.4.2. Latin America Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
9.4.3. Latin America Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Procedure, 2019-2031
9.4.4. Latin America Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
9.4.5. Latin America Aspiration & Biopsy Needles Market revenue (US$ Million) By country, (US$ Million) 2019-2031
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Aspiration & Biopsy Needles Market revenue (US$ Million) By Product, (US$ Million)
9.5.2. Middle East & Africa Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
9.5.3. Middle East & Africa Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By Procedure, 2019-2031
9.5.4. Middle East & Africa Aspiration & Biopsy Needles Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
9.5.5. Middle East & Africa Aspiration & Biopsy Needles Market revenue (US$ Million) By country, (US$ Million) 2019-2031
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. CONMED Corporation (US)
10.2.2. Medtronic Plc (Ireland)
10.2.3. Olympus Corporation (Japan)
10.2.4. Becton, Dickinson and Company (US)
10.2.5. Boston Scientific Corporation (US)
10.2.6. Cook Group Incorporated (US)
10.2.7. Argon Medical Devices, Inc (US)
10.2.8. INRAD Inc. (US)
10.2.9. Somatex Medical Technologies (Germany)
10.2.10. Stryker Corporation (US)
10.2.11. Cardinal Health (US)
10.2.12. Remington Medical (US)
10.2.13. Ranfac Corporation (US)
10.2.14. HAKKO CO., LTD (Japan)
10.2.15. Merit Medical Systems (US)
Aspiration & Biopsy Needles Market By Product-
Aspiration & Biopsy Needles Market By Application-
Aspiration & Biopsy Needles Market By Procedure-
Aspiration & Biopsy Needles Market By End-User-
Aspiration & Biopsy Needles Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
